The International Liver Conference - Ahead: Nash In Focus

The International Liver Conference – Ahead: NASH in Focus

The International Liver Conference – New Prospects for Dealing With NASH

EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclature

EASL - Home of Hepatology

Conference about NASH disease in New York City - International NASH Day 2019

The NASH Education Program

Conference about NASH disease in Brussels - International NASH Day 2019

The NASH Education Program

USER TALK: Deep Phenotyping of the Human Liver for NAFLD (NASH) Target Discovery

The International Liver Congress 2013 - Mauro Bernardi

EASL - Home of Hepatology

The International Liver Congress™ 2018 (ILC) - Press Conference 3

EASL - Home of Hepatology

Global Liver Institute NASH Externally-Led Patient-Focused Drug Development Meeting

Global Liver Institute

The International Liver Congress™ 2018 (ILC) - Press Conference 1

EASL - Home of Hepatology

1st Annual Mount Sinai MASLD/MASH (NAFLD/NASH) Center of Excellence Symposium – Part 1

Icahn School of Medicine

Official Press Conference ILC 2022 - NAFLD (Friday, 24 June)

EASL - Home of Hepatology

EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?

EASL - Home of Hepatology

News on NASH – Selected Highlights From the AASLD Liver Meeting 2022

NASH Day Panel - NASH and Obesity

Global Liver Institute

Webinar: EASL Update - FibroScan Applications in NAFLD-NASH

Echosens North America

EASL Policy Dialogues - Liver disease representation at the 4th high level meeting on NCDs in 2025

EASL - Home of Hepatology

EASL Studio S4E23 - The Conundrum of NASH

EASL - Home of Hepatology

Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials-D2-AM

U.S. Food and Drug Administration

The International Liver Congress™ 2018 (ILC) - Press Conference 2

EASL - Home of Hepatology